Bio.Revive Mucin + by Invivo — Ingredients, Evidence & Safety

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

3 Capsule(s) Serving Size

30 Servings

Other Combinations Product Type

40% Evidence Coverage

Supplement Facts — Evidence Check

Muco-Save

500 mg

Brown Seaweed Polysaccharides

250 mg

Aronia melanocarpa Extract

250 mg

N-Acetyl Glucosamine

500 mg

📊 Market median: 1000.0mg (1115 products) 📚 22 studies (Tier A: 0, B: 9)

This product: 500mg

Quercetin

200 mg

📊 Market median: 500.0mg (283 products) 📚 173 studies (Tier A: 0, B: 62)

This product: 200mg

Other Ingredients

Hydroxypropyl Methylcellulose Spirulina

Label Claims — Verification

❓ All Other

❓ Structure/Function

All Other (100% of products) Structure/Function (89% of products) Nutrient (16% of products)

Target Groups

Vegan Vegetarian Adult (18 - 50 Years) Women (not pregnant or lactating) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Directions: Take 3 capsules daily. Mucin+ is normally well tolerated, but if you have a sensitive stomach, start with 1 capsule and build up gradually to the full dosage.

⚠️ Warnings & Precautions

Do not exceed the recommended dose, unless advised by your healthcare professional.

Not suitable for use during pregnancy or lactation. If you are taking medication or are under medical supervision please consult your healthcare practitioner before use.

Food supplements are not a substitute for a varied and balanced diet or lifestyle.

Keep out of reach of children.

🧪 Formulation Notes

A phytonutrient formula for mucosal membranes

GMO-free Gluten-free Dairy-free

Vegan

Additional Information

Store in the original packaging, at room temperature, in a dry place.

Certified B Corporation

Carbon Neutral

GMP Certified

Product Details

UPC / SKU 7 105353 660758

DSLD Entry Date 2022-02-23

Product Type Other Combinations

Form Capsule

Brand Invivo

DSLD ID 259868

Data Updated 2026-04-11

Research Evidence

39 Research Sources

50 Avg Quality Score

20 Rct

9 Meta Analysis

4 Clinical Trial

3 Systematic Review

1 Regulatory Source

1 Openfda Safety

B Interventions for the management of temporomandibular joint osteoarthritis

Systematic Review The Cochrane database of systematic reviews 2012

PubMed DOI Cochrane

B Glucosamine therapy for treating osteoarthritis

Meta Analysis The Cochrane database of systematic reviews 2005

PubMed Cochrane

B Chondroitin for osteoarthritis

Meta Analysis The Cochrane database of systematic reviews 2015

PubMed DOI Cochrane

B Efficacy and safety of the combination of glucosamine and chondroitin for knee osteoarthritis: a systematic review and meta-analysis

Meta Analysis Archives of orthopaedic and trauma surgery 2023

PubMed DOI

B Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis

Rct The New England journal of medicine 2006

PubMed

B Oral Glucosamine in the Treatment of Temporomandibular Joint Osteoarthritis: A Systematic Review

Systematic Review International journal of molecular sciences 2023

PubMed DOI

B Scientific Opinion on glucosamine and joint health

Regulatory Source EFSA Journal 2009

DOI

B Clinical Efficacy and Safety of Chondroitin Combined with Glucosamine in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis

Meta Analysis Computational and mathematical methods in medicine 2022

PubMed DOI

B Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib

Rct Annals of the rheumatic diseases 2016

PubMed DOI

B Effectiveness and safety of glucosamine and chondroitin for the treatment of osteoarthritis: a meta-analysis of randomized controlled trials

Meta Analysis Journal of orthopaedic surgery and research 2018

PubMed DOI

View all evidence for Glucosamine →